Related Experiment Video
Updated: Aug 9, 2026
Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy
Published on: February 26, 2021
PROGRESSIVE RETINOPATHY IN A PATIENT WITH MUCOPOLYSACCHARIDOSIS TYPE II UNDERGOING ENZYME REPLACEMENT THERAPY: A CASE
Margot C Wouters1, Michel Van Lint
1Department of Ophthalmology, Antwerp University Hospital, Edegem, Belgium Faculty of Health Sciences, University of Antwerp, Edegem, Belgium.
Purpose:
The aim of this study was to report the changing fundus autofluorescence (FAF) and ocular coherence tomographic (OCT) findings through time in a patient with mucopolysaccharidosis type II being treated with idursulfase, an enzyme replacement therapy (ERT).
Methods:
This was a case report with clinical photography.
Results:
The authors report the case of a 27-year-old male patient with mucopolysaccharidosis type II whom they followed from 2019 to 2023. Throughout the follow-up, the authors noticed a slow increase of parafoveal outer retinal atrophy centripetally, which is reflected in a smaller hyperautofluorescent ring and increasing ring scotoma on visual field testing. The patient remains asymptomatic.
Conclusion:
Despite continuing long-term enzyme replacement treatment with idursulfase, the retinopathy associated with mucopolysaccharidosis type II progressed in the patient.
More Related Videos
11:20Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
11:06Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
Published on: November 11, 2022
